张家口输精管结扎术训练模型北京高级着装式乳房自检模型,西藏高级婴儿头部综合静脉穿刺模型,郑州缺失伸长模型,沈阳卵巢解剖放大模型,巴彦淖尔肾脏放大模型,武汉两倍牙体牙髓解剖,神经元模型价格

The Food and Drug Administration says it is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks.In response to questioning at a budget hearing last week, FDA Commissioner Scott Gottlieb told members of Congress that he would "take another look" at Nuplazid, which is the only drug approved to treat hallucinations and delusions associated with Parkinson's disease psychosis.The medication has been cited as a so-called "suspect" medication in hundreds of deaths voluntarily reported by caregivers, doctors and other medical professionals since it hit the market, as highlighted in a recent CNN report.The FDA told CNN this week that the agency had already begun conducting a new evaluation of the medication when Gottlieb was questioned about it at the hearing. The agency said the review had started several weeks ago."What does it take for a drug like this to be taken off the market?" asked US Rep. Rosa DeLauro, a member and former chair of the congressional subcommittee responsible for funding and overseeing the FDA.DeLauro pressed Gottlieb for answers on his agency's response to the safety concerns surrounding Nuplazid."How many more adverse events do we have to have reported? How many people, quite frankly, have to die? Why does the industry always take precedence over public health and safety?"Tracked by the FDA, the adverse event reports cited by DeLauro do not mean that a suspected medication has been ruled the cause of harm and are typically not the result of official investigations. But the FDA uses the information to monitor potential issues with a drug and can take action as needed: updating a medication's label, for instance, or restricting its use. In rare cases, the agency can even pull a drug off the market.When asked by CNN about what prompted the FDA's new evaluation of Nuplazid, the agency said the decision was based on a number of factors but wouldn't say what those factors were. Instead, it would only comment generally, saying that it identifies "potential signals of serious risk/new safety information" in part by using adverse event data and that the agency is not suggesting physicians stop prescribing the drug or take patients off of it while a safety evaluation is taking place.The FDA has noted that the death reports citing Nuplazid have typically involved elderly patients with advanced-stage Parkinson's disease who suffered from numerous medical conditions and often take other medications that can increase the risk of death.But physicians, researchers and other medical experts told CNN that the high number of reports deserved a closer look to determine whether they were related to the drug. They also recommended further testing of Nuplazid, worrying that the drug had been approved too quickly, based on too little evidence that it was safe or effective.Nuplazid's review was expedited by the FDA because it had been designated a "breakthrough therapy," meaning it demonstrated "substantial improvement" in patients with serious or life-threatening diseases compared to treatments already on the market.Dr. Paul Andreason, the physician who led the FDA's medical review of Nuplazid, warned that patients taking the drug during the company's clinical trials experienced serious outcomes, including death, at more than double the rate of those taking the placebo. But the FDA ruled that the potential benefits outweighed the risks, agreeing with an advisory committee that cited a lack of safe alternatives and the pleas from family members who claimed the drug was already helping or could help their loved ones.At that advisory committee meeting two years ago, one woman said that her grandmother had been part of the clinical trials for the drug and that Nuplazid had been life-changing."We didn't know what to expect or even if she was on the drug" or a placebo, said Zoey Wade. "We soon realized that she must be taking the drug, because she really returned to herself. Her hallucinations reduced, and she better understood what was real and what was imaginary."Shortly after Nuplazid's release, however, patients' family members, doctors and other health care professionals started reporting "adverse events" possibly linked to the medication -- including deaths, life-threatening incidents, falls, insomnia, nausea and fatigue.During the first 10 months Nuplazid was on the market, 244 deaths were reported to the FDA in which Nuplazid was a "suspect" medication, according to an analysis conducted by the Institute for Safe Medication Practices. FDA data now show that the number of reported deaths has risen to more than 700. In more than 1,000 reports, patients continued to experience hallucinations while on Nuplazid.After CNN published its investigation on Nuplazid, reporters were contacted by family members who said the drug helped tame hallucinations with few apparent side effects and others who said they believe Nuplazid contributed to their family member's decline or death. Some said they had not yet reported these experiences to the drugmaker or the FDA.While the FDA has long been criticized for being too slow to approve drugs, DeLauro seized on its push to streamline the process, lambasting the agency for putting industry interests and efficiency above public health and safety.DeLauro described the number of adverse events and deaths as "staggering" and "unprecedented." She also expressed concern that the drugmaker, Acadia Pharmaceuticals, is attempting to get the drug approved for a larger population: patients who suffer from dementia-related psychosis."I don't know why it should stay on the market, especially when the FDA has not determined it to be safe and while the number of adverse events continues to soar," she told Gottlieb.In response to the congresswoman's remarks, Acadia told CNN that adverse event data alone are "not a comprehensive and accurate indicator of the safety profile of any drug." In response to CNN's earlier report on the drug, Acadia said there are a number of reasons for the higher volume of death reports, including the fact that the company distributes Nuplazid through a network of specialty pharmacies that puts the company in more frequent contact with both patients and caregivers -- meaning Acadia is more likely to receive reports of death, which it is required to pass along to the FDA.Commissioner Gottlieb told the committee that the FDA is careful about the decisions it makes and that there may be a higher tolerance for risk in situations where there is an unmet medical need, "so long as the patient is properly informed of what those risks are." This echoed what he told CNN's Dr. Sanjay Gupta in an interview earlier this month.The FDA previously told CNN that it was aware of Nuplazid's "complex safety profile" at the time of approval and required the drugmaker to place warnings on its labeling. The agency also said that, though it was continuing to monitor available information about Nuplazid, it had "not identified a specific safety issue" not already reflected on the medication's label.DeLauro's office told CNN that it plans to follow up with the FDA about its inquiry into Nuplazid. 7224

The coroner misidentified two of the Humboldt Broncos hockey players involved in a fatal bus crash, according to the Royal Canadian Mounted Police.Xavier Labelle, who was originally listed among the deceased, is actually alive, while Parker Tobin, who had been listed among the survivors, died as a result of the Friday collision, the RCMP said in a Monday news release."The Office of the Chief Coroner apologizes for the misidentification and any confusion created by it," the news release said. "The Coroner's office extends its deepest sympathies to the families and friends of those who lost their lives as well as those who were involved in the collision."At a news conference, a spokesman for the Saskatchewan Ministry of Justice said the young men involved in the crash were similar ages and builds, and the teammates had dyed their hair blond in solidarity for the Broncos' playoff run."A lot of these boys looked alike," Drew Wilby said.Dental records are the best way to ensure an identification is accurate, and it takes time to procure those records, especially considering some of the players hail from British Columbia, a province hundreds of miles to the west, the spokesman said."New information came to light last night that raised questions with the health care professionals," Wilby said, adding that the information was not related to dental records.Health care professionals were then able to correctly identify Labelle, and the Labelle and Tobin families were notified Sunday night, he said.The Labelle and Tobin families were involved in the initial identification processes, Wilby said, without elaborating.Citing Canadian privacy laws, Wilby declined to provide details of Labelle's injuries other than to say he is "an active patient in the system."After being informed that Labelle had died, brother Isaac Labelle told CNN he was at the gym when he got a text about the bus wreck. He called his father, an emergency room doctor, who had been en route to the game but had changed course to the crash site.Once there, Isaac Labelle said, his father told him that there didn't appear to be any survivors. Isaac Labelle went on to say his brother was "well-loved by everybody.""I also want people to know the good person he is," he said.The Labelle family could not be immediately reached to discuss the news that Xavier Labelle had been misidentified.Tobin is among the 15 killed in the crash in Canada's Saskatchewan province. The death toll includes nine other Broncos players, two coaches, two employees of a broadcasting company and the bus driver.The crash occurred around 5 p.m. Friday north of Tisdale, according to the Royal Canadian Mounted Police, as the team was headed for the town of Nipawin for a playoff game. RCMP Assistant Commissioner Curtis Zablocki said the tractor-trailer, traveling west on Highway 335, collided with the bus, which was traveling north on Highway 35.The cause of the crash is not known, and "the scope and complexity of this investigation means it will take some time to determine the cause of the collision and the circumstances surrounding it," said RCMP Assistant Commissioner Curtis Zablocki.The tragedy was felt across Canada, where hockey is the dominant sport and many young players take long bus rides to tournaments.Humboldt, a town of about 6,000, has a tradition of fielding teams in the Saskatchewan Junior Hockey League. The players, ranging in age from 16 to 21, come from different parts of Canada and stay with host families during the season, according to?the team's website."Our Broncos family is in shock as we try to come to grips with our incredible loss," Kevin Garinger, the team's president, said in a statement.The hockey community and others rallied around the victims and their families, offering financial assistance.By Monday morning, a GoFundMe page for the players and their families had raised more than .8 million, the result of about 70,000 donations. 3998

The Catholic Diocese of Pittsburgh has received about 50 new allegations of abuse in the week since a grand jury report was published about sexual abuse by priests, according to diocese spokesman Rev. Nicholas Vaskov, as reported in the Pittsburgh Post Gazette."All of the allegations are from prior to 1990 and go back as far as the 1940s," Vaskov said in a statement to the Post Gazette.CNN has reached out to the Catholic Diocese of Pittsburgh but has yet to hear back.None of the new allegations have yet been turned over to prosecutors, according to the district attorney's office in Allegheny County.Mike Manko, the spokesman for the district attorney, told CNN he was "not aware of any new referrals."The new allegations come in the wake of a Pennsylvania grand jury report that documented decades of alleged sexual abuse by priests and a system of cover-ups by Church higher-ups. Citing internal documents from six Catholic dioceses -- including Pittsburgh -- the report showed that more than 300 priests had been credibly accused of sexually abusing more than 1,000 children. 1092

The fury of the lava from the Kilauea volcano swallowed a car whole.A time lapse video from Brandon Clement shows a Ford Mustang being consumed on the Big Island.The video from the lava and ash flow across the road, eventually overtaking the car on the side of the road. 278

The Florida Panthers have hired Brett Peterson as an assistant general manager, making him the first Black executive to hold that position in the NHL. "I'm very excited for this opportunity with the Panthers and with Bill's growing front office team," said Peterson in a press release. "It's a special day for myself and my family and I can't wait to get to work."Peterson's hiring comes days after the nearby Miami Marlins hired Kim Ng as the first female GM in Major League Baseball. The NHL has been working to increase minority participation in front offices and on coaching staffs. Peterson has a background as a player agent just like GM Bill Zito and fellow assistant Paul Krepelka. The 39-year-old was previously vice president of hockey for Wasserman Media Group and has been an NHLPA certified agent since 2009.Peterson also played professional hockey and made it up as far as the American Hockey League level. He also played at Boston College and won a National Championship with them in 2001. 1012